Literature DB >> 22355801

Mitochondrial biology and Parkinson's disease.

Celine Perier1, Miquel Vila.   

Abstract

Mitochondria are highly dynamic organelles with complex structural features which play several important cellular functions, such as the production of energy by oxidative phosphorylation, the regulation of calcium homeostasis, or the control of programmed cell death (PCD). Given its essential role in neuronal viability, alterations in mitochondrial biology can lead to neuron dysfunction and cell death. Defects in mitochondrial respiration have long been implicated in the etiology and pathogenesis of Parkinson's disease (PD). However, the role of mitochondria in PD extends well beyond defective respiration and also involves perturbations in mitochondrial dynamics, leading to alterations in mitochondrial morphology, intracellular trafficking, or quality control. Whether a primary or secondary event, mitochondrial dysfunction holds promise as a potential therapeutic target to halt the progression of dopaminergic neurodegeneration in PD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22355801      PMCID: PMC3281591          DOI: 10.1101/cshperspect.a009332

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  127 in total

1.  Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease.

Authors:  Chang-Lin Liang; Tom T Wang; Kate Luby-Phelps; Dwight C German
Journal:  Exp Neurol       Date:  2006-09-28       Impact factor: 5.330

2.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

3.  Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons.

Authors:  Mark J Barsoum; Hua Yuan; Akos A Gerencser; Géraldine Liot; Yulia Kushnareva; Simone Gräber; Imre Kovacs; Wilson D Lee; Jenna Waggoner; Jiankun Cui; Andrew D White; Blaise Bossy; Jean-Claude Martinou; Richard J Youle; Stuart A Lipton; Mark H Ellisman; Guy A Perkins; Ella Bossy-Wetzel
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

4.  Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators.

Authors:  Julie St-Pierre; Stavit Drori; Marc Uldry; Jessica M Silvaggi; James Rhee; Sibylle Jäger; Christoph Handschin; Kangni Zheng; Jiandie Lin; Wenli Yang; David K Simon; Robert Bachoo; Bruce M Spiegelman
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults.

Authors:  Mitsugi Okawara; Hiroshi Katsuki; Emi Kurimoto; Haruki Shibata; Toshiaki Kume; Akinori Akaike
Journal:  Biochem Pharmacol       Date:  2006-11-09       Impact factor: 5.858

Review 6.  Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.

Authors:  Damien J Keating
Journal:  J Neurochem       Date:  2007-10-25       Impact factor: 5.372

7.  PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.

Authors:  Hung-Li Wang; An-Hsun Chou; Tu-Hsueh Yeh; Allen H Li; Ying-Ling Chen; Yu-Li Kuo; Shu-Ru Tsai; Szu-Tzu Yu
Journal:  Neurobiol Dis       Date:  2007-07-17       Impact factor: 5.996

8.  OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.

Authors:  Christian Frezza; Sara Cipolat; Olga Martins de Brito; Massimo Micaroni; Galina V Beznoussenko; Tomasz Rudka; Davide Bartoli; Roman S Polishuck; Nika N Danial; Bart De Strooper; Luca Scorrano
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

9.  Structural and functional features and significance of the physical linkage between ER and mitochondria.

Authors:  György Csordás; Christian Renken; Péter Várnai; Ludivine Walter; David Weaver; Karolyn F Buttle; Tamás Balla; Carmen A Mannella; György Hajnóczky
Journal:  J Cell Biol       Date:  2006-09-18       Impact factor: 10.539

10.  Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease.

Authors:  Mathieu Marella; Byoung Boo Seo; Eiko Nakamaru-Ogiso; J Timothy Greenamyre; Akemi Matsuno-Yagi; Takao Yagi
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

View more
  105 in total

Review 1.  PGC-1α: a master gene that is hard to master.

Authors:  Dan Lindholm; Ove Eriksson; Johanna Mäkelä; Natale Belluardo; Laura Korhonen
Journal:  Cell Mol Life Sci       Date:  2012-06-09       Impact factor: 9.261

2.  Quantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parameters.

Authors:  Lyle Wiemerslage; Daewoo Lee
Journal:  J Neurosci Methods       Date:  2016-01-14       Impact factor: 2.390

3.  BAX channel activity mediates lysosomal disruption linked to Parkinson disease.

Authors:  Jordi Bové; Marta Martínez-Vicente; Benjamin Dehay; Celine Perier; Ariadna Recasens; Agnes Bombrun; Bruno Antonsson; Miquel Vila
Journal:  Autophagy       Date:  2014-03-26       Impact factor: 16.016

4.  Loss of PINK1 causes age-dependent decrease of dopamine release and mitochondrial dysfunction.

Authors:  Lianteng Zhi; Qi Qin; Tanziyah Muqeem; Erin L Seifert; Wencheng Liu; Sushuang Zheng; Chenjian Li; Hui Zhang
Journal:  Neurobiol Aging       Date:  2018-11-02       Impact factor: 4.673

5.  Comparative analysis of Parkinson's disease-associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons.

Authors:  Nicolas Giguère; Consiglia Pacelli; Caroline Saumure; Marie-Josée Bourque; Diana Matheoud; Daniel Levesque; Ruth S Slack; David S Park; Louis-Éric Trudeau
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

Review 6.  Gene therapy targeting mitochondrial pathway in Parkinson's disease.

Authors:  Chi-Jing Choong; Hideki Mochizuki
Journal:  J Neural Transm (Vienna)       Date:  2016-09-16       Impact factor: 3.575

7.  ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.

Authors:  Valentín Cóppola-Segovia; Clarissa Cavarsan; Flavia G Maia; Anete C Ferraz; Lia S Nakao; Marcelo Ms Lima; Silvio M Zanata
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

8.  Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease.

Authors:  Bong-Suk Choi; Hyool Kim; Hyo Jeong Lee; Kumar Sapkota; Se Eun Park; Seung Kim; Sung-Jun Kim
Journal:  Neurochem Res       Date:  2013-11-09       Impact factor: 3.996

Review 9.  Lysosomal impairment in Parkinson's disease.

Authors:  Benjamin Dehay; Marta Martinez-Vicente; Guy A Caldwell; Kim A Caldwell; Zhenyue Yue; Mark R Cookson; Christine Klein; Miquel Vila; Erwan Bezard
Journal:  Mov Disord       Date:  2013-04-11       Impact factor: 10.338

10.  Antioxidant-Rich Fraction of Urtica dioica Mediated Rescue of Striatal Mito-Oxidative Damage in MPTP-Induced Behavioral, Cellular, and Neurochemical Alterations in Rats.

Authors:  Rohit Bisht; Bhuwan Chandra Joshi; Ajudhiya Nath Kalia; Atish Prakash
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.